Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-16

Clinical Trial Update: LycoRed 40051 Product as a Countermeasure to Exercise Stress [NA]

View source ↗

Summary

A completed clinical trial update evaluating LycoRed 40051 Product as a countermeasure to exercise-induced inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LycoRed 40051 Product

Snippet

Sponsor: Appalachian State University | Conditions: Inflammation | NA | Status: COMPLETED